The
biggest AHA advantages are to reach high implantation rates in some
patients and recover pre-embryos with ZP abnormalities and excessive
cytoplasmic fragmentation. It has been shown concomitantly that
pre-embryos in hatching implant earlier than those ones having na
intact ZP, which can cause a more intimate embryo-uterus synchronization
relationship, during the implantation period.
Patient’s
immunesupression before transference of pre-embryos in hatching
is a preventive measure that helps reduce the possible contact between
uterus immune cells and the exposed pre-embryo.
Pre-embryo
fragmentation is one of the main factors in IVF failure. Fragmentation
reduces the available cytoplasm for succesive blastomere divisions,
and fragments having no nucleus can go through apoptosis, which
is potentially harmful for viable blastomeres. Early fragment removal,
for these reasons, help some embryos to manifest all its growth
potential. Fragment removal attempts to imitate the natural process
of apoptotic cell elimination by the immune system (apoptotic cell
assisted removal), since pre-embryos and fragments express the apoptotic
markers precociously in their cell membranes. These markers signalize,
physiologically, their imminent removal. In reality, the role of
apoptotic processes during the development of human pre-embryos
needs to be better studied.
The
introduction of new techniques, like LASER and PIEZOMANIPULATION,
have provided us with new and exciting directions for AHA. Piezomanipulation
is especially promising, because it doesn’t involve exposition
to chemical agents. Technical advances will propitiate improvement
in the control of the size opened in the ZP and blastomere protection.
AHA
has been a success when aplied to pre-embryos with a poor implantation
diagnosis, and can be combined with co-culture. However, a very
small opening made in the ZP leads to na impairment in the natural
process of hatching and possibly promotes the formation of monozygotic
twins. On the other hand, if the opening is too large, it can cause
blastomere loss during transference. AT solution, which has low
pH, may have adverse effects on the blastomere viability if incorrectly
manipulated. Finally, as human pre-embryos do not express polarization
during compactation, the exact place in the ZP where natural hatching
will occur cannot be identified. Consequently, the ideal place to
perform the artificial opening, or even if there is any importance
in choosing a place to pierce the embryo, must still be certified.
The
identification of embryos with best implantation probability will
select the best embryos for AHA and transference. The death cause
determination of the pre-embryo in vitro and the application of
non invasive techniques to determine apoptotic blastomeres will
allow their selective removal. The determination of pre-embryo viability
using vital atoxic colorants and genetic markers will allow us to
transfer only healthy embryos in the future, and thus enhance implantation
rates.
Concluding, AHA is no miraculous technique, although there is growing
evidence of its benefit in specific cases. It is a very secure technique
when used by na experienced embryologist. The AHA technique itself
still presents controversies and different results in different
centers, different AHA procedures and different experience levels.